Chronisch entzündliche Darmerkrankungen
Petra Hartmann und Bernd Bokemeyer, CNE Fortbildung, 04/2012

Clinical status, psychosocial impairments, medical treatment and health care costs for patients with inflammatory bowel disease (IBD) in Germany: An online IBD registry.
Bokemeyer B, Hardt J, Hüppe D, Prenzler A, Conrad S, Düffelmeyer M, Hartmann P, Hoffstadt M, Klugmann T, Schmidt C, Weismüller J, Mittendorf T, Raspe H.
J Crohns Colitis. 2012 Apr 11. [Epub ahead of print]

Mesalazine in left-sided ulcerative colitis: Efficacy analyses from the PODIUM trial on maintenance of remission and mucosal healing.
Bokemeyer B, Hommes D, Gill I, Broberg P, Dignass A.
J Crohns Colitis. 2012 May;6(4):476-82. Epub 2011 Nov 10.

Predictors for subsequent need for immunosuppressive therapy in early Crohn's disease.
Wenger S, Nikolaus S, Howaldt S, Bokemeyer B, Sturm A, Preiss JC, Schoepfer AM, Stallmach A, Schmidt C.
J Crohns Colitis. 2012 Feb;6(1):21-8. Epub 2011 Jul 18.

[Epidemiology and clinical characteristics of patients with chronic hepatitis B (CHB) in Germany - results of a nationwide cross-sectional study].
Fischer C, Mauss S, Zehnter E, Bokemeyer B, Heyne R, Hüppe D.
Z Gastroenterol. 2012 Jan;50(1):22-9. Epub 2012 Jan 5. German.

[Updated German guideline on diagnosis and treatment of ulcerative colitis, 2011].
Dignass A, Preiss JC, Aust DE, Autschbach F, Ballauff A, Barretton G,
Bokemeyer B, Fichtner-Feigl S, Hagel S, Herrlinger KR, Jantschek G, Kroesen A, Kruis W, Kucharzik T, Langhorst J, Reinshagen M, Rogler G, Schleiermacher D, Schmidt C, Schreiber S, Schulze H, Stange E, Zeitz M, Hoffmann JC, Stallmach A.
Z Gastroenterol. 2011 Sep;49(9):1276-341. Epub 2011 Aug 24. German. No abstract available.

[Pharmacotherapy in patients with ulcerative colitis].
Scherer M, Hardt J, Blozik E, Preiss JC,
Bokemeyer B, Hüppe A, Raspe H.
Z Gastroenterol. 2011 Jul;49(7):820-6. Epub 2011 Jul 15. German.

FERGIcor, a randomized controlled trial on ferric carboxymaltose for iron deficiency anemia in inflammatory bowel disease.
Evstatiev R, Marteau P, Iqbal T, Khalif IL, Stein J,
Bokemeyer B, Chopey IV, Gutzwiller FS, Riopel L, Gasche C; FERGI Study Group.
Gastroenterology. 2011 Sep;141(3):846-853.e1-2. Epub 2011 Jun 12.

Health care costs and their predictors of inflammatory bowel diseases in Germany.
Prenzler A,
Bokemeyer B, von der Schulenburg JM, Mittendorf T.
Eur J Health Econ. 2011 Jun;12(3):273-83. Epub 2010 Oct 22.

Predictors for subsequent need for immunosuppressive therapy in early Crohn's disease.
Wenger S, Nikolaus S, Howaldt S, Bokemeyer B, Sturm A, Preiss JC, Schoepfer AM, Stallmach A, Schmidt C.

J Crohns Colitis. 2012 Feb;6(1):21-8. Epub 2011 Jul 18.

FERGIcor, a randomized controlled trial on ferric carboxymaltose for iron deficiency anemia in inflammatory bowel disease.
Evstatiev R, Marteau P, Iqbal T, Khalif IL, Stein J, Bokemeyer B, Chopey IV, Gutzwiller FS, Riopel L, Gasche C; FERGI Study Group.
Gastroenterology. 2011 Sep;141(3):846-853.e1-2.

Epidemiology and clinical characteristics of patients with chronic hepatitis B (CHB) in Germany - results of a nationwide cross-sectional study.
Fischer C, Mauss S, Zehnter E, Bokemeyer B, Heyne R, Hüppe D.
Z Gastroenterol. 2012 Jan;50(1):22-9.

Updated German guideline on diagnosis and treatment of ulcerative colitis, 2011.
Dignass A, Preiss JC, Aust DE, Autschbach F, Ballauff A, Barretton G, Bokemeyer B, Fichtner-Feigl S, Hagel S, Herrlinger KR, Jantschek G, Kroesen A, Kruis W, Kucharzik T, Langhorst J, Reinshagen M, Rogler G, Schleiermacher D, Schmidt C, Schreiber S, Schulze H, Stange E, Zeitz M, Hoffmann JC, Stallmach A.
Z Gastroenterol. 2011 Sep;49(9):1276-341.

Pharmacotherapy in patients with ulcerative colitis.
Scherer M, Hardt J, Blozik E, Preiss JC, Bokemeyer B, Hüppe A, Raspe H.
Z Gastroenterol. 2011 Jul;49(7):820-6.

Health care costs and their predictors of inflammatory bowel diseases in Germany.
Prenzler A, Bokemeyer B, von der Schulenburg JM, Mittendorf T.
Eur J Health Econ. 2011 Jun;12(3):273-83.

A randomised placebo-controlled multicentre trial of intravenous semapimod HCl for moderate to severe Crohn's disease.
Dotan I, Rachmilewitz D, Schreiber S, Eliakim R, van der Woude CJ, Kornbluth A, Buchman AL, Bar-Meir S, Bokemeyer B, Goldin E, Maaser C, Mahadevan U, Seidler U, Hoffman JC, Homoky D, Plasse T, Powers B, Rutgeerts P, Hommes D; Semapimod-CD04/CD05 Investigators.
Gut. 2010 Jun;59(6):760-6.

Inflammatory bowel diseases as multi-focal disorders: results from a multi-regional survey on bodily and psychosocial problems in IBD patients.
Hardt J, Muche-Borowski C, Conrad S, Balzer K, Bokemeyer B, Raspe H.
Z Gastroenterol. 2010 Mar;48(3):381-91.

Costs of ulcerative colitis within the German Statutory Health Insurance.
Prenzler A, Bokemeyer B, Mittendorf T, von der Schulenburg JM.
Dtsch Med Wochenschr. 2010 Feb;135(7):281-6.

Costs of Crohn's disease in Germany from the perspective of the Statutory Health Insurance.
Prenzler A, Mittendorf T, Conrad S, von der Schulenburg JM, Bokemeyer B.
Z Gastroenterol. 2009 Jul;47(7):659-66.

Screening colonoscopy for colorectal cancer prevention: results from a German online registry on 269000 cases.
Bokemeyer B, Bock H, Hüppe D, Düffelmeyer M, Rambow A, Tacke W, Koop H.
Eur J Gastroenterol Hepatol. 2009 Jun;21(6):650-5.

Mesalamine once daily is more effective than twice daily in patients with quiescent ulcerative colitis.
Dignass AU, Bokemeyer B, Adamek H, Mross M, Vinter-Jensen L, Börner N, Silvennoinen J, Tan G, Pool MO, Stijnen T, Dietel P, Klugmann T, Vermeire S, Bhatt A, Veerman H.
Clin Gastroenterol Hepatol. 2009 Jul;7(7):762-9

Clinical practice guideline on diagnosis and treatment of Crohn's disease - summary for the general practitioner.
Preiss JC, Bokemeyer B, Siegmund B, Stange EF, Zeitz M, Hoffmann JC; German Gastroenterologic Society and the Competence Network IBD.
Med Klin (Munich). 2009 Mar 15;104(3):237-43.

Clinical practice guideline on diagnosis and treatment of Crohn's disease.
Hoffmann JC, Preiss JC, Autschbach F, Buhr HJ, Häuser W, Herrlinger K, Höhne W, Koletzko S, Krieglstein CF, Kruis W, Matthes H, Moser G, Reinshagen M, Rogler G, Schreiber S, Schreyer AG, Sido B, Siegmund B, Stallmach A, Bokemeyer B, Stange EF, Zeitz M.
Z Gastroenterol. 2008 Sep;46(9):1094-146.

Short version of the updated German S3 (level 3) guideline on diagnosis and treatment of Crohn's disease.
Hoffmann JC, Autschbach F, Bokemeyer B, Buhr HJ, Herrlinger K, Höhne W, Krieglstein C, Kruis W, Moser G, Preiss JC, Reinshagen M, Rogler G, Schreiber S, Schreyer AG, Siegmund B, Stallmach A, Stange EF, Zeitz M.
Dtsch Med Wochenschr. 2008 Sep;133(38):1924-9.

Course of Crohn's disease prior to establishment of the diagnosis.
Albert JG, Kotsch J, Köstler W, Behl S, Kaltz B, Bokemeyer B, Dollinger MM, Haerting J, Fleig WE.
Z Gastroenterol. 2008 Feb;46(2):187-92.

Epidemiology of chronic hepatitis C in Germany--an analysis of 10,326 patients in hepatitis centres and outpatient units.
Hüppe D, Zehnter E, Mauss S, Böker K, Lutz T, Racky S, Schmidt W, Ullrich J, Sbrijer I, Heyne R, Schober A, John C, Hey KH, Bokemeyer B, Kallinowski B, Möller B, Pape S, Gutmann M, Alshuth U, Niederau C.
Z Gastroenterol. 2008 Jan;46(1):34-44.

A systematic survey evaluating 6-thioguanine-related hepatotoxicity in patients with inflammatory bowel disease.
Teml A, Schwab M, Hommes DW, Almer S, Lukas M, Feichtenschlager T, Florin T, Seiderer J, Petritsch W, Bokemeyer B, Kreisel W, Herrlinger KR, Knoflach P, Bonaz B, Klugmann T, Herfarth H, Pedarnig N, Reinisch W.
Wien Klin Wochenschr. 2007;119(17-18):519-26.

Adherence to thiopurine treatment in out-patients with Crohn's disease.
Bokemeyer B, Teml A, Roggel C, Hartmann P, Fischer C, Schaeffeler E, Schwab M.
Aliment Pharmacol Ther. 2007 Jul 15;26(2):217-25.

Surveillance colonoscopy in ulcerative colitis patients in Germany.
Kaltz B, Bokemeyer B, Hoffmann J, Porschen R, Rogler G, Schmiegel W.
Z Gastroenterol. 2007 Apr;45(4):325-31.

Randomized, double blind controlled trial of subcutaneous recombinant human interleukin-11 versus prednisolone in active Crohn's disease.
Herrlinger KR, Witthoeft T, Raedler A, Bokemeyer B, Krummenerl T, Schulzke JD, Boerner N, Kueppers B, Emmrich J, Mescheder A, Schwertschlag U, Shapiro M, Stange EF.
Am J Gastroenterol. 2006 Apr;101(4):793-7.

Clinical trials in Germany. The gastroenterologist in private practice as a partner in clinical trials.
Bokemeyer B.
Dtsch Med Wochenschr. 2004 Apr 2;129(14):764-6.

Cost of general medical care of patients suffering from chronic inflammatory bowel disease.
Bokemeyer B.
Z Gastroenterol. 2003 Sep;41(9):963-4.

Asymptomatic elevation of serum lipase and amylase in conjunction with Crohn's disease and ulcerative colitis.
Bokemeyer B.
Z Gastroenterol. 2002 Jan;40(1):5-10.

Wahrnehmung der Schutzimpfung gegen die Neue Grippe H1N1 von Patienten mit Morbus Crohn oder Colitis ulcerosa
Teich, N; Schmidt, C; Stallmach, A; Klugmann, T; Vieth, M; Baumgart, D C; Sturm, A; Felten, G; Hüppe, D; Emmrich, J; Böcker, U; Maaser, C; Bästlein, E C; Ehehalt, R; Krummenerl, T; Bachmann, O; Kruis, W; Mroß, M; Herrlinger, K; Helwig, U; Büning, J; Aschenbeck, J; Siegmund, B; Preiß, J; Maul, J; Drossel, R; Schiefke, I; Reinshagen, M; Heidemann, J; Lügering, A; Rehbehn, K U; Pfeiffer, A; Jessen, P; Schreiber, S; Rosezin, B; Dignaß, A; Böhm, S; Bokemeyer, B; German IBD Study Group:
Dtsch med Wochenschr 2011; 136: 939-943


Die Vorsorgekoloskopie in Deutschland - der aktuelle Stand
Bokemeyer, B.; Hüppe, D.:
Endo-Praxis 2010; 26: 62-68


Kosten der Colitis ulcerosa - eine Kalkulation aus der Perspektive der Gesetzlichen Krankenversicherung
Prenzler, A; Bokemeyer, B; Mittendorf, T; Schulenburg, J-M Graf von der:
Dtsch med Wochenschr 2010; 135: 281-286


Value of iron supplementation in gastrointestinal bleeding
Prassler R. Deppe H., Huchzermeyer H.
Leber Magen Darm 28 (1) 1998, 21 – 23

Antibiotikaprophylaxe bei perkutaner endoskopischer Gastrostomie
Dormann AJ, Wigginghaus B, Risius H, Kleimann F., Kloppenburg A., Deppe H., Huchzermeyer H.
Chemotherapiejournal 3/2000

Modified percutaneous endoscopic gastrostomy (PEG) with gastropexy – early experience with a new introducer technique
Dormann AJ, Glosemeyer R. Leistner U., Deppe H., Roggel R. Wigginghaus B., Huchzermeyer H.
Z Gastroenterol 2000 Dec; 38(12): 933 – 8

Self-expanding metallic stents for continuous dilatation of benign stenosis in gastrointestinal tract – first results of long-term follow-up in interim stent application in pyloric and colonic obstructions
Dormann AJ, Deppe H., Wigginghaus B
Z Gastroenterol 2001 Nov, 39(11): 957 – 60

Patientenmanagement in der interdisziplinären Notaufnahme
Deppe H, Domann AJ
Führen und Wirtschaften (F&W) im Krankenhaus, 6/2001; 594-8

Retrieval of a dialocated stent from the ductus hepaticus dexter using a new balloon system.
Wejda BU, Deppe H, Huchzermeyer H, Dormann AJ
Z Gastroenterol. 2004;42(6):548-549


Skinlevel gastrostomy – longterm results from a prospective trial in gastric and jejeunal application.
Dormann AJ, Deppe H, Kahl S, Wejda B, Malfertheiner P
Z Gastroenterol 2004;42(11):12831288

Duodenal ileus due to an intramural duodenal haematoma following anticoagulation.
Hill H, Deppe H, Huchzermeyer H, Dormann AJ
Dtsch Med Wochenschr. 2005;130(3):924

Duodenal ileus due to an intramural duodenal haematoma. Conservative therapy using a multiple lumen intestinal probe
Hill H, Deppe H, Huchzermeyer H, Dormann AJ..
Dtsch Med Wochenschr. 2005 Jan 21;130(3):924.

Placement of a jejunal enteral tube through a percutaneous endoscopic jejunostomy to prevent recurrent aspiration during intestinal feeding.
Luttmann A, Deppe H, Wejda BU, Huchzermeyer H, Dormann AJ.
Gastrointest Endosc. 2005;61(3):4923

Interdisziplinäre Behandlung des Rektumkarzinoms
Geier A, Deppe H, Willis S, Holy R, Trautwein C., Gartung
DMW 2006; 131: 1945 - 1950

Uferstr. 3 · 32423 Minden · Telefon: 0571/22567 · Fax: 0571/84249 · E-Mail